Prestigious international institutions have initiated robust psychedelic research programs. Does Australia risk being left behind if it doesn’t do the same?
New research published in the Australian Psychologist Journal claims Australia is missing out on the benefits of using psychedelic drugs to treat a range of mental health illnesses.
On 9th April 2018 The Project (Channel Ten) interviewed PRISM co-founders Dr Stephen Bright and Steve McDonald about the need for Australia to embrace formal research into psychedelic medicines.
Scientists believe the illegal drug MDMA, also known as ecstasy, has an untapped potential to treat post-traumatic stress disorder (PTSD). But they say plans to test the drug on war veterans in [...]
This presentation was delivered by PRISM Vice-President Dr Stephen Bright at a fundraising seminar and dinner held at The Melbourne Brain Centre, Parkville on 8th April 2016.
In September 2016 PRISM’s Vice President Dr Stephen Bright spoke at Beyond Psychedelics, a global multidisciplinary psychedelic forum held in Prague, Czech Republic.
Some drugs that have therapeutic benefits are banned because of emerging patterns of use that do not conform to dominant paradigms. Such policies are often driven by morality rather than evidence.
In April 2014 PRISM’s President Martin Williams and Vice President Stephen Bright were invited to join a panel discussion at the Melbourne screening of Neurons to Nirvana,
Illegal recreational drugs including LSD, ecstasy and cannabis should be considered as alternative treatments for conditions such as post-traumatic stress disorder and anxiety,
4BC Health and Wellbeing: MDMA has been proven to help treat Post Traumatic Stress Disorder Research suggests that Psychoactive drugs like MDMA and LSD have other therapeutic benefits.
PRISM will be presenting a panel discussion at the 2013 Australian Professional Society on Alcohol and other Drugs Scientific Conference 24-27 November in Brisbane.
Story by Jill Stark, published in The Sunday Age (Melbourne) ECSTASY pills would be given to Australian bushfire victims, flood survivors and soldiers suffering post-traumatic stress disorder,